When was Biosynex SA stock made available for the first time to the public?

The IPO Date for Biosynex SA is 2011-03-28. On this 2011-03-28, Biosynex SA stock was made publicly available.

Where is the headquarters of Biosynex SA stock?

Headquarters information for Biosynex SA is currently unavailable. We'll update this as soon as it's available.

What industry does Biosynex SA belong to?

The Biosynex SA belongs to Medical - Diagnostics & Research.

Biosynex SA

ALBIO.PA•EURONEXT

Healthcare

Medical - Diagnostics & Research

€1.22

€-0.02(-1.61%)

Biosynex SA (ALBIO.PA) Company Profile & Overview

Explore Biosynex SA’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Biosynex SA (ALBIO.PA) Company Profile & Overview

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.

SectorHealthcare

IndustryMedical - Diagnostics & Research

CEOLarry Abensur

Contact Information

https://www.biosynex.com

33 3 88 78 78 87

22 Boulevard Sébastien Brant, Illkirch-Graffenstaden, 67400

Company Facts

515 Employees

IPO DateMar 28, 2011

CountryFR

Actively Trading

Frequently Asked Questions

;